|
1
|
Neoptolemos JP, Stocken DD, Friess H,
Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C,
Lacaine F, et al: A randomized trial of chemoradiotherapy and
chemotherapy after resection of pancreatic cancer. N Engl J Med.
350:1200–1210. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zlotnik A and Yoshie O: Chemokines: A new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ben-Baruch A: The multifaceted roles of
chemokines in malignancy. Cancer Metastasis Rev. 25:357–371. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zlotnik A: Chemokines and cancer. Int J
Cancer. 119:2026–2029. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ding Y, Shimada Y, Maeda M, Kawabe A,
Kaganoi J, Komoto I, Hashimoto Y, Miyake M, Hashida H and Imamura
M: Association of CC chemokine receptor 7 with lymph node
metastasis of esophageal squamous cell carcinoma. Clin Cancer Res.
9:3406–2412. 2003.PubMed/NCBI
|
|
6
|
Tutunea-Fatan E, Majumder M, Xin X and
Lala PK: The role of CCL21/CCR7 chemokine axis in breast
cancer-induced lymphangiogenesis. Mol Cancer. 14:352015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Irino T, Takeuchi H, Matsuda S, Saikawa Y,
Kawakubo H, Wada N, Takahashi T, Nakamura R, Fukuda K, Omori T and
Kitagawa Y: CC-Chemokine receptor CCR7: A key molecule for lymph
node metastasis in esophageal squamous cell carcinoma. BMC Cancer.
14:2912014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oliveira-Neto HH, de Souza PP, da Silva
MR, Mendonça EF, Silva TA and Batista AC: The expression of
chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous
cell carcinoma and its relevance to cervical lymph node metastasis.
Tumor Biol. 34:65–70. 2013. View Article : Google Scholar
|
|
9
|
Al-Shareef H, Hiraoka SI, Tanaka N, Shogen
Y, Lee AD, Bakhshishayan S and Kogo M: Use of NRP1, a novel
biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict
lymph node metastasis in squamous cell carcinoma of the tongue.
Oncol Rep. 36:2444–2454. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo J, Lou W, Ji Y and Zhang S: Effect of
CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human
pancreatic ductal adenocarcinoma. Oncol Lett. 5:1572–1578. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Sun R, Tao K and Wang G: The
CCL21/CCR7 pathway plays a key role in human colon cancer
metastasis through regulation of matrix metalloproteinase-9. Dig
Liver Dis. 43:40–47. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma H, Gao L, Li S, Qin J, Chen L, Liu X,
Xu P, Wang F, Xiao H, Zhou S, et al: CCR7 enhances TGF-β1-induced
epithelial-mesenchymal transition and is associated with lymph node
metastasis and poor overall survival in gastric cancer. Oncotarget.
6:24348–24360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu FY, Safdar J, Li ZN, Fang QG, Zhang X,
Xu ZF and Sun CF: CCR7 regulates cell migration and invasion
through JAK2/STAT3 in metastatic squamous cell carcinoma of the
head and neck. Biomed Res Int. 2014:4153752014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu FY, Safdar J, Li ZN, Fang QG, Zhang X,
Xu ZF and Sun CF: CCR7 regulates cell migration and invasion
through MAPKs in metastatic squamous cell carcinoma of head and
neck. Int J Oncol. 45:2502–2510. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kunzelmann K, Nilius B, Owsianik G,
Schreiber R, Ousingsawat J, Sirianant L, Wanitchakool P, Bevers EM
and Heemskerk JW: Molecular functions of anoctamin 6 (TMEM16F): A
chloride channel, cation channel, or phospholipid scramblase?
Pflugers Arch. 466:407–414. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miettinen M: Immunohistochemistry of soft
tissue tumours-review with emphasis on 10 markers. Histopathology.
64:101–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jacobsen KS, Zeeberg K, Sauter DR, Poulsen
KA, Hoffmann EK and Schwab A: The role of TMEM16A (ANO1) and
TMEM16F (ANO6) in cell migration. Pflugers Arch. 465:1753–1762.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu S, Xing W, Peng J, Yuan X, Zhao X, Lei
P, Li W, Wang M, Zhu H, Huang B, et al: Tumor transfected with
CCL21 enhanced reactivity and apoptosis resistance of human
monocyte-derived dendritic cells. Immunobiology. 213:417–426. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li K, Xu B, Xu G and Liu R: CCR7 regulates
Twist to induce the epithelial-mesenchymal transition in pancreatic
ductal adenocarcinoma. Tumour Biol. 37:419–424. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giovannetti E, van der Borden CL, Frampton
AE, Ali A, Firuzi O and Peters GJ: Never let it go: Stopping key
mechanisms underlying metastasis to fight pancreatic cancer. Semin
Cancer Biol. 44:43–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakata B, Fukunaga S, Noda E, Amano R,
Yamada N and Hirakawa K: Chemokine receptor CCR7 expression
correlates with lymph node metastasis in pancreatic cancer.
Oncology. 74:69–75. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sperveslage J, Frank S, Heneweer C,
Egberts J, Schniewind B, Buchholz M, Bergmann F, Giese N, Munding
J, Hahn SA, et al: Lack of CCR7 expression is rate limiting for
lymphatic spread of pancreatic ductal adenocarcinoma. Int J Cancer.
131:E371–E381. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mo M, Zhou M, Wang L, Qi L, Zhou K, Liu
LF, Chen Z and Zu XB: CCL21/CCR7 enhances the proliferation,
migration, and invasion of human bladder cancer T24 cells. PLoS
One. 10:e01195062015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shang L, Hao JJ, Zhao XK, He JZ, Shi ZZ,
Liu HJ, Wu LF, Jiang YY, Shi F, Yang H, et al: ANO1 protein as a
potential biomarker for esophageal cancer prognosis and
precancerous lesion development prediction. Oncotarget.
7:24374–24382. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Szteyn K, Schmid E, Nurbaeva MK, Yang W,
Münzer P, Kunzelmann K, Lang F and Shumilina E: Expression and
functional significance of the Ca(2+)-activated Cl(−) channel ANO6
in dendritic cells. Cell Physiol Biochem. 30:1319–1332. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng S, Guo J, Yang Q and Yang X:
Crk-like adapter protein regulates CCL19/CCR7-mediated
epithelial-to-mesenchymal transition via ERK signaling pathway in
epithelial ovarian carcinomas. Med Oncol. 32:472015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Zhou Y and Yang Y: CCR7 pathway
induces epithelial-mesenchymal transition through up-regulation of
Snail signaling in gastric cancer. Med Oncol. 32:4672015.PubMed/NCBI
|
|
30
|
Li G, Yang Y, Xu S, Ma L, He M and Zhang
Z: Slug signaling is up-regulated by CCL21/CCR7 [corrected] to
induce EMT in human chondrosarcoma. Med Oncol. 32:4782015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Su ML, Chang TM, Chiang CH, Chang HC, Hou
MF, Li WS and Hung WC: Inhibition of chemokine (C-C motif) receptor
7 sialylation suppresses CCL19-stimulated proliferation, invasion
and anti-anoikis. PLoS One. 9:e988232014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang L, Wang D, Li Y, Liu Y, Xie X, Wu Y,
Zhou Y, Ren J, Zhang J, Zhu H and Su Z: CCL21/CCR7 axis contributed
to CD133+ pancreatic cancer stem-like cell metastasis via EMT and
Erk/NF-κB pathway. PLoS One. 11:e01585292016. View Article : Google Scholar : PubMed/NCBI
|
